```text
Wiki Article
Tesidolumab (LFG316, 1531594-08-7): A Research Tool for Immunological Studies
Tesidolumab, identified as LFG316, bearing the CAS number 1531594-08-7, serves as a essential scientific reagent for promoting immune studies. The protein primarily interacts with a defined target linked to immune mediated reactions, allowing it to be used employed to probe the basis of immune regulation. Scientists utilize this compound to gain insights into illness occurrence and to uncover potential therapeutic strategies. The existence as an substance supports thorough assessment within cell culture and in vivo models.
```
```text
Investigating Tesidolumab (LFG316) in Research Applications
Researchers are increasingly studying the research application of tesidolumab (LFG316) in a variety of research studies. Preliminary results suggest this compound could enable crucial perspectives into pathways underlying allergic conditions . Specifically, future work focus on characterizing its influence on leukocyte function and molecule secretion, with the goal of discovering innovative biological markers and potentially improving innovative treatment strategies.
```
Tesidolumab LFG316: Examining Future Study Directions
Further study into the drug LFG316 provides promising avenues for ongoing research. Key areas of exploration could include:
- Analyzing its effectiveness in distinct individual groups, particularly those affected by severe chronic ailments.
- Defining the exact process of action and its influence on physiological reactions.
- Exploring potential biomarkers that forecast treatment response and enable for customized care.
- Examining the extended security profile and discovering any anticipated adverse effects.
Research Grade Tesidolumab (1531594-08-7) – Characteristics and Applications
Tesidolumab, identified by the catalog number 1531594-08-7, is a research grade antibody currently being studied for its therapeutic potential in allergic diseases . Exceptional quality is guaranteed through rigorous analytical testing processes, resulting in a product typically exhibiting a purity of ≥95% as measured by SEC . Usual presentations are available as a sterile, lyophilized powder, requiring reconstitution with a compatible buffer. Investigational uses for this biological include, but are not limited to, preclinical studies relating to inflammatory pathways. Further information Tesidolumab for research regarding detailed information can be obtained through the accompanying literature.
- MW : Approximately 145 kDa
- Storage : -20°C or colder
- Reconstitution : Phosphate-buffered saline
Tesidolumab for Research : Procurement and Administration
Accessing this therapeutic for experimental purposes requires careful consideration and adherence to strict guidelines . Currently, Tesidolumab is generally available through specialized contract research organizations, often through a limited release program. Obtaining typically involves a detailed submission process specifying the intended study design. Administering this compound demands expertise; it's usually supplied in a lyophilized form requiring specific instruments for thawing and storage .
- Careful temperature control is imperative.
- Adequate personal safety gear must be utilized .
- Debris elimination should follow accepted institutional protocols.
```text
Revealing Knowledge with the Compound: A Research Tool (1531594-08-7)
Analysts working with Tesidolumab (1531594-08-7), a critical research reagent, have started to uncover important understanding into complex biological functions. This compound delivers a specific possibility for analyzing disease courses and potential therapeutic goals. Further experiments involving Tesidolumab suggest to yield significant improvements in the area of immunology.
```
Report this wiki page